MicroRNA-26b inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting USP9X.
about
La FAM fatale: USP9X in development and diseaseThe role of exosomes contents on genetic and epigenetic alterations of recipient cancer cellsmicroRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathwayThe PDGF-D/miR-106a/Twist1 pathway orchestrates epithelial-mesenchymal transition in gemcitabine resistance hepatoma cells.Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.Conserved miR-26b enhances ovarian granulosa cell apoptosis through HAS2-HA-CD44-Caspase-3 pathway by targeting HAS2.MiR-502-3P suppresses cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting SET.MiR-144 suppresses cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting SMAD4.Twist1-related miR-26b-5p suppresses epithelial-mesenchymal transition, migration and invasion by targeting SMAD1 in hepatocellular carcinoma.Down-regulation of β-arrestin2 promotes tumour invasion and indicates poor prognosis of hepatocellular carcinomaApigenin inhibits NF-κB and snail signaling, EMT and metastasis in human hepatocellular carcinoma.USP9X destabilizes pVHL and promotes cell proliferation.MicroRNA Mediating Networks in Granulosa Cells Associated with Ovarian Follicular DevelopmentProof-of-concept study: profile of circulating microRNAs in Bovine serum harvested during acute and persistent FMDV infection.MicroRNA in ovarian function.miR-26b enhances radiosensitivity of hepatocellular carcinoma cells by targeting EphA2MiR-26b inhibits hepatocellular carcinoma cell proliferation, migration, and invasion by targeting EphA2.MicroRNA-26b inhibits metastasis of osteosarcoma via targeting CTGF and Smad1.WAVE3 promotes epithelial-mesenchymal transition of gastric cancer through upregulation of Snail.Targeting Deubiquitinating Enzymes in Glioblastoma Multiforme: Expectations and Challenges.Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role.Regulation of proliferation, angiogenesis and apoptosis in hepatocellular carcinoma by miR-26b-5p.Epithelial-mesenchymal, mesenchymal-epithelial, and endothelial-mesenchymal transitions in malignant tumors: An update.Mcl-1 Is a Novel Target of miR-26b That Is Associated with the Apoptosis Induced by TRAIL in HCC Cells.Dual effects of constitutively active androgen receptor and full-length androgen receptor for N-cadherin regulation in prostate cancer.MicroRNA-26b functions as a proapoptotic factor in porcine follicular Granulosa cells by targeting Sma-and Mad-related protein 4.Targeting deubiquitinating enzymes in cancer stem cells.MiR-26b reverses temozolomide resistance via targeting Wee1 in glioma cells.miR-26a-5p suppresses tumor metastasis by regulating EMT and is associated with prognosis in HCC.Deubiquitinase inhibitor PR-619 reduces Smad4 expression and suppresses renal fibrosis in mice with unilateral ureteral obstruction
P2860
Q27025293-EB53C8EF-7574-41C0-9B83-CD86E3321297Q28069899-DD19944C-5FFB-4AEF-9698-31C71A45632FQ35664592-1358D661-12EF-4206-BC8E-6F053DFA397DQ35740131-6CDEB119-11D6-4C2C-899C-ED9F571A7074Q35854256-25D761F8-22F6-4FA2-ADF5-4DF072C7C4B4Q36592055-32276802-5DA2-464A-B49D-B9A813FC934FQ36982248-84291322-44F6-4760-A954-75700FF5550AQ37152535-FA4EBF43-9024-4885-8B78-2BBF279097B7Q37269315-FA18071C-F22C-41C3-BE3C-BD077BF118B8Q37349092-14581491-2203-4EF9-B034-CB0170B2C089Q37520250-48D679B2-5035-4E67-B3E3-BB7E9669D545Q37645058-DF9A44E2-C972-41C7-BF25-4EC50A221FA4Q37681525-CC001DA2-E13A-4087-9B5D-85D36298DD66Q37741183-BD421BCA-2DA6-4080-B886-7455F215F9F6Q38630504-B5BA8509-D05A-49BD-89BB-30DC26CF8014Q38740875-078F05D7-2217-4244-88A4-47530898EC8FQ38851292-A8D19AA4-0900-4367-A16A-64F95B6461CFQ38901007-0A052288-C47E-4E62-B0EB-25617027A5C5Q38942065-37893426-2262-4E32-9D99-35E4BECB4157Q38989377-ECB99B04-FF87-44C9-B0BA-8D3167680647Q39346497-A8A33783-609A-44A7-B53F-0480E8285DB8Q39986591-94CDDE8D-6893-4B6A-800D-198F6D7F6E26Q40245310-856D941B-CA68-4ECC-B1B2-3C8EF68880FCQ42180490-29247504-4C79-4373-8234-B9EA2EE0ED04Q42700843-93797032-CB43-4BBE-AC52-80324425F01BQ44784192-5CD078A5-EBDF-4E96-A2BA-FA919943FB53Q44948244-6299B664-2E91-4390-B7D5-5F695130A10DQ50133239-18CFB4CD-47F7-475C-A850-0E56C191E20BQ52958669-7E2236D7-3014-4EA8-BBF3-898B345F932AQ58774942-0A1E5543-FD8D-4831-9F93-823F3D95B390
P2860
MicroRNA-26b inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting USP9X.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
MicroRNA-26b inhibits epitheli ...... carcinoma by targeting USP9X.
@ast
MicroRNA-26b inhibits epitheli ...... carcinoma by targeting USP9X.
@en
type
label
MicroRNA-26b inhibits epitheli ...... carcinoma by targeting USP9X.
@ast
MicroRNA-26b inhibits epitheli ...... carcinoma by targeting USP9X.
@en
prefLabel
MicroRNA-26b inhibits epitheli ...... carcinoma by targeting USP9X.
@ast
MicroRNA-26b inhibits epitheli ...... carcinoma by targeting USP9X.
@en
P2093
P2860
P356
P1433
P1476
MicroRNA-26b inhibits epitheli ...... carcinoma by targeting USP9X.
@en
P2093
P2860
P2888
P356
10.1186/1471-2407-14-393
P407
P577
2014-06-02T00:00:00Z
P5875
P6179
1047959217